Monday, 17 August 2026
PERSPECTA
News from every angle
All
Stream
World
Politics
Business
Technology
Finance
Science
Health
Culture
Opinion
Environment
← Back to headlines
Eton Pharmaceuticals forecasts 2026 revenue to exceed $145M while targeting adjusted EBITDA margin above 35%
14 Aug, 05:47 — 14 Aug, 05:47
Post
Share
Copy link
Embed
Sources
Sort: Relevance
Sort: Latest
Sort: Bias (L→R)
Sort: Bias (R→L)
Sort: Factuality
left
center
right
Showing 1 of 1 sources
seeking-alpha
Mixed
3d ago
Eton Pharmaceuticals forecasts 2026 revenue to exceed $145M while targeting adjusted EBITDA margin above 35%
Read full article →
Something wrong with this story? Report an issue
Related Stories
China's Industrial Output and Retail Sales Slow in July, Missing Forecasts
58m ago
Stock Futures Mixed Ahead of Key Retail Earnings Reports
1h ago
Greece Achieves €5.7 Billion Primary Surplus in Seven Months
1h ago
Seven Dead in India Hotel Fire
1h ago
Monday, 17 August 2026
Explore
Log in
Sign up
en
PERSPECTA
News from every angle
